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Edited by Vladimir SkulachevAbstract Exposure of biological material to high levels of free
radicals causes extensive cellular damage. Reactive oxygen spe-
cies (ROS) generated by mitochondria have been associated with
a variety of diseases and aging. We investigated the eﬀect of low-
level mitochondrial ROS production on newly synthesized
mitochondrial proteins which are potentially vulnerable to mito-
chondrial ROS due to their location and unfolded state. We show
that elevated mitochondrial ROS increases the degradation of
newly synthesized mitochondrial proteins with some proteins more
sensitive than others. In the long term reduced assembly of mito-
chondrial complexes would aﬀect mitochondrial function and may
trigger a vicious cycle of mitochondrial ROS production.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Protein oxidation has been implicated in a wide range of
neurodegenerative diseases including Freidreichs ataxia [1],
Parkinsons disease [2] and Alzheimerss disease [3], as well
as in normal aging [3]. Proteins damaged by oxidative stress
are targeted for degradation by the 20S subunit of the mam-
malian proteasome (cytoplasm) and the lon protease (mito-
chondria) [4–8]. Severely oxidized proteins show increased
resistance to the cellular degradation machinery, potentially
forming toxic aggregates [5,9,10]. Most in vivo and cell based
models investigating the mechanisms of free radical damage
have utilized extra-cellular oxidants added to the tissue culture
media rather than taking advantage of the cells own free rad-Abbreviations: ROS, reactive oxygen species; CFTR, cystic ﬁbrosis
transmembrane conductance regulator; DMEM, Dulbeccos modiﬁed
Eagles media; FCS, fetal calf serum; MTT, 3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyltetrazolium bromide; PBS, phosphate buﬀered saline;
FACS, ﬂuorescence activated cell sorting; FITC, ﬂuorescein isothio-
cyanate; EDTA, ethylenediaminetetra-acetic acid; DCFH-DA, dichlo-
rodihydroﬂuorescein diacetate; NAC, N-acetyl cysteine; SDS, sodium
dodecyl sulphate; HSP60, heat shock protein 60; IEF, isoelectric
focusing; PAGE, polyacrylamide gel electrophoresis; PDH, pyruvate
dehydrogenase; PI, propidium iodide
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ease states where oxidative damage is likely to be caused by
mitochondrially generated radicals, we have developed a cell
culture model which generates intra-mitochondrial radicals.
Unlike many previous studies, we have utilized a level of intra-
cellular radicals, which in the short term are non-toxic to the
cell, have no aﬀect on cell viability and do not signiﬁcantly im-
pair mitochondrial enzymes known to be susceptible to oxida-
tive stress.
The main objective of this study was to determine the sus-
ceptibility of newly synthesized mitochondrial proteins to
oxidative damage. These proteins are likely to be especially
vulnerable to free radical damage as they are transported
in a partially unfolded state from the cytosol to the mito-
chondria. It is clear from a variety of genetic disorders that
alterations to protein structure can severely aﬀect a proteins
stability resulting in mutant proteins that are degraded be-
fore they are assembled [11–13]. One example is the inten-
sively studied DF508 mutation in the cystic ﬁbrosis
transmembrane conductance regulator (CFTR) chloride
channel causing cystic ﬁbrosis. When the DF508 mutation
is present the CFTR protein is targeted for degradation
and degraded at a much faster rate than the wild type mol-
ecule resulting in a deﬁciency of the CFTR in the membrane
[14,15]. If a similar type of quality control machinery exists
within the mitochondria preventing aberrant proteins from
being fully assembled, it is possible that oxidative protein
modiﬁcations could aﬀect protein folding targeting modiﬁed
proteins for degradation. In the long term the removal of
oxidized damaged proteins during assembly would result in
enzyme deﬁciency and if respiratory chain complexes are af-
fected cause respiratory chain dysfunction and further reac-
tive oxygen species (ROS) production.
In this study we use a C2C12 myoblast cell culture model
to study the eﬀects of low levels of mitochondrial radicals
on newly synthesized mitochondrial protein turnover. Newly
synthesized mitochondrial proteins showed a general acceler-
ated rate of newly synthesized protein turnover as a result of
oxidative stress. At the single protein level, newly synthe-
sized mitochondrial proteins showed a heterogeneous re-
sponse to oxidative stress indicating that oxidative damage
at the protein level is likely to be selective. If taken further
the methodologies used in this study will allow the identiﬁ-
cation of protein targets of oxidative stress potentially high-
lighting enzyme/protein complexes that are likely targets of
oxidative stress in vivo.blished by Elsevier B.V. All rights reserved.
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2.1. Cell culture
C2C12 mouse myoblasts were obtained from the American Tissue
Culture Collection. Cultures were grown in Dulbeccos modiﬁed
Eagles media (DMEM, Sigma) supplemented with, 10% fetal calf
serum (FCS, PAA laboratories), 100 lg/ml streptomycin (Sigma) and
100 U/ml penicillin (Britannia Pharmaceuticals Ltd.) in normoxic
conditions (air plus 5% CO2).
2.2. Mitochondrial dehydrogenase activity
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bro-
mide) assay has been used as a simple test for cell viability and a general
assay for dehydrogenase activity [16–19]. As most dehydrogenase activ-
ity in C2C12 myoblasts comes from mitochondrial dehydrogenases we
used theMTTassayas an indicatorof howmenadione treatment aﬀected
mitochondrial function. One of the main contributors to theMTT reac-
tion is theROS sensitivemitochondrial enzyme succinatedehydrogenase
[20–22]. Cells were grown in 24 well plates to 80% conﬂuency and either
treatedwithmenadione orDMEM.Cells werewashed in phosphate buf-
fered saline (PBS) andMTT was added to the wells for a 2 h incubation
period at 37 C. The MTT was then removed and dimethyl sulphoxide
was added to dissolve the purple formazan crystals formed. The absor-
bance (570 nm) was measured for each sample.
2.3. FACS determination of cell viability using ﬂuorescein isothiocyanate
(FITC)-labeled Annexin-V and propidium iodide
C2C12 myoblasts were grown to 80% conﬂuency and treated with
menadione or DMEM for 1 h at 37 C. Cells were washed in PBS, fol-
lowed by incubation inDMEMcontaining 10%FCS for 24 h. Cells were
harvested using 0.05% trypsin–0.53 mM ethylenediaminetetra-acetic
acid (EDTA) and subjected toAnnexin-V-FITC and proprodium iodide
(PI) staining using a BenderMed Systems kit. Annexin-V and PI staining
was determined using ﬂuorescence activated cell sorting (FACS) ﬂow
cytometer (Becton–Dickinson, San Jose,CA,USA)with a 488 nmargon
laser and CellQuest software used for acquisition and analysis of data.
For each analysis 10000 events were recorded.
2.4. Intracellular free radical determination using dichlorodihydro-
ﬂuorescein diacetate (DCFH-DA) and lucigenin
Cells were grown to 80% conﬂuency and washed with PBS. Cells
were left untreated or treated with 1 mM menadione or 1 mM menadi-
one plus10 mM N-acetyl cysteine (NAC), and incubated for 1 h at
37 C. Cells were subsequently washed in PBS and harvested by adding
0.05% trypsin–0.53 mM EDTA. The cells were then resuspended in
1.5 ml DMEM and centrifuged at 1600 · g for 5 min. The supernatants
were aspirated and cell pellets resuspended in 1 ml DMEM and
DCFH-DA added to a ﬁnal concentration of 8.7 mM. The tubes were
wrapped in foil and left for 1 h at 37 C. Cells were centrifuged at
1600 · g for 5 min, supernatants were discarded and the cell pellets
washed in PBS (2·). Oxidation of DCF-DA (525 nm) was determined
using FAC analysis by excitating cells at 488 nm and measuring emis-
sion at 510–560 nm. Data were acquired and analyzed using CellQuest
software. For each analysis 10000 events were recorded.
Intracellular superoxide levels were measured using a lucigenin-
derived chemiluminescence assay [23]. Cells were pre-incubated with
lucigenin at 37 C for 15 min before the addition of 1 mM menadione
with and without the antioxidant, NAC. Following the addition of
menadione, superoxide measurements were measured as relative light
units over a 30-min period, at room temperature.
2.5. Newly synthesized mitochondrial protein degradation analysis
C2C12 cells grown to 90% conﬂuency were starved of L-methionine
by incubating for 1 h at 37 C, 5% CO2 in methionine free DMEM
containing 10% dialyzed FCS (10000 molecular weight cut oﬀ). 35S
L-methionine labeling (250 lCi/ml)(Amersham) was carried out in
methionine free DMEM (10% dialyzed FCS) for 2 h at 37 C, 5%
CO2. Unincorporated radioactivity was removed by washing with
PBS (4·) and cells harvested to give a zero (t0) time point for maximal
protein labeling. The remaining metabolically labeled cells were sub-
jected to either a 1 h pulse of 75 lM menadione or incubated in stan-
dard tissue culture media. A cold chase was inititiated by washing 3
times in DMEM and incubating in standard DMEMmedia containingexcess cold L-methionine (6 mM) to reduce the chance of radiolabeled
proteins being synthesized during the cold chase period. Cells were har-
vested at diﬀerent time points and mitochondria harvested using a stan-
dard diﬀerential centrifugation. Mitochondria were re-suspended in
homogenizing buﬀer (20 mM Tris–HCl and 200 mM sucrose, pH 7.5)
at 4 C, supplemented with 100 lM digitonin and left on ice for
30 min. Cells were homogenized and centrifuged at 2000 · g for
10 min, at 4 C. The mitochondria containing supernatants were dec-
anted and the pellets resuspended in homogenizing buﬀer and further
extracted. The supernants were combined and the mitochondrial frac-
tion pelleted by centrifugation at 18500 · g for 10 min at 4 C. Mito-
chondrial proteins were extracted in 50 mM phosphate buﬀer, pH 7.4,
containing 1% sodium dodecyl sulphate (SDS), 1% Triton X-100,
0.5 lg/ml leupeptin, 200 lM phenylmethylsulphonic ﬂuoride and
0.5 lg/ml aprotinin. Proteins were subjected to standard SDS–PAGE
and gels dried before being subjected to phosphoimage analysis using
Amersham Pharmacia/Molecular dynamics phosphoimaging systems.
The levels of radioactive proteins at the diﬀerent time points was quan-
tiﬁed and standardized by calculating the level of radioactivity per mg
of protein loaded.Mitochondrial protein enrichment was assessed using
antibodies to the mitochondria matrix protein Hsp60 and the cytoskel-
etal protein B-actin. Following mitochondrial isolation Hsp60 levels in-
creased over 100-fold relative to B-actin (data not shown).
2.6. 2D gel mitochondrial protein degradation analysis
Mitochondrial proteins (0.25 mg) were precipitated with 80% ice-
cold acetone for 4 h at 20 C. The precipitates were centrifuged at
20000 · g for 15 min at 4 C and the pellets left to air dry. The pellets
were resuspended in sample buﬀer (6 M Urea, 2 M thiourea, 2%
Chaps, 2% IPG buﬀer, 0.3% dithiothreitol, trace bromophenol blue).
Samples were subjected to isoelectric focusing (IEF) using pH gradient
3-10 IPG strips on an Amersham IPGphor system. Once IEF focused,
strips were resolved in a second dimension using 12% SDS–PAGE gels
on the Ettan Dalt system (Amersham). Following electrophoresis, gels
were ﬁxed in 12% TCA for 1 h, rinsed in distilled water for 20 min and
then silver stained. Gels for degradation analysis were dried and left in
a phosphoimaging cassette for 2–3 days prior to radioactivity quanti-
ﬁcation using a Storm S860 and imagequant software.
2.7. Statistical analysis
The data were analyzed using a Students unpaired t-test with P-
values of less than 0.05 being considered signiﬁcant. n denotes the
number of times an experiment was carried out in triplicate.3. Results
3.1. The majority of newly synthesized mitochondrial proteins
are turned over very rapidly
By utilizing a short pulse 35S-metabolic labeling strategy and
isolating mitochondria we were able to determine the fate of
newly synthesized proteins. Using this approach we observed
that newly synthesized mitochondrial proteins in C2C12 myo-
blasts show very fast rates of decay (Fig. 1). A 2 h metabolic
labeling step followed by a 22 h cold chase resulted in
95% ± 1.4% of the mitochondrial proteins being degraded
24 h after synthesis, the majority of degradation occurring
within 7 h of synthesis (Fig. 1).
3.2. Menadione exposure increases levels of cellular ROS
Exposure of C2C12 myoblasts to menadione resulted in the
generation of free radicals (Fig. 2) and inactivation of mito-
chondrial dehydrogenases as measured by the MTT assay.
Co-exposure of C2C12 myoblasts to menadione in the pres-
ence of the antioxidant NAC signiﬁcantly reduced levels of
radicals generated (Fig. 2A and B(iii)). NAC also had a protec-
tive aﬀect on sensitive mitochondrial dehydrogenases as
measured by the MTT assay, reducing inhibition following co-
exposure with 1 mM menadione in a dose dependent fashion.
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Fig. 1. Newly synthesized mitochondrial protein degradation following exposure to menadione induced oxidative stress. C2C12 cells were
metabolically labeled with 35S-L-methionine and subjected to a short 1 h pulse of 75 lM menadione. A single 1 h pulse of 75 lM menadione did not
aﬀect ROS susceptible mitochondrial enzyme function or activated cell death pathways during the time frame of the experiment (Fig. 3). The eﬀect of
menadione treatment on newly synthesized mitochondrial protein degradation was determined by measuring the loss of radiolabeled protein
following menadione treatment (a full experimental protocol is outlined in Section 2.3). Protein degradation was determined by measuring the decay
rate of radioactively labeled proteins as visualized on SDS–PAGE. The data are represented as a percentage of the time 0 value (2 h labeling but no
menadione treatment) and indicates the decay of newly synthesized mitochondrial proteins over time. The data shown were compiled from nine
separate ﬂasks from three independent experiments.
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levels following 1 mM menadione exposure to 16% ± 1.8%,
27% ± 1%, 50% ± 2% and 60% ± 1.5% of untreated levels fol-
lowing co-exposure with 100 lM, 1, 5 and 10 mM NAC,
respectively (Percentage changes relative to untreated levels
following NAC and 1 mM menadione exposure are the means
of four independent experiments.) 1, 5, 10 mMNAC co-exposure
with 1 mM menadione signiﬁcantly increasing mitochon-
drial dehydrogenase activity compared to 1 mM menadione
treatment alone (P < 0.05)).
3.3. Low levels of menadione induced oxidative stress does not
aﬀect cell viability but increases the rate of mitochondrial
protein turnover
To examine the eﬀects of mitochondrial free radicals on
mitochondrial protein turnover without the possible con-
founds of triggered cell death pathways we titrated the eﬀects
of diﬀerent concentrations of menadione on cell viability. This
was carried out in conjunction with the short methionine star-
vation step used in the metabolic labeling experiments, which
increased cellular stress prior to menadione exposure. A single
1 h pulse of 75 lM menadione proved to be the highest dose
which could be given to C2C12 myoblasts and not aﬀect cell
viability 72 h after treatment (data not shown). Cell death
was determined using annexin V-propridium iodide staining
and showed no evidence of induction of early apoptotic path-
ways or necrosis in 75 lM menadione treated C2C12 myo-
blasts 24 h after treatment (Fig. 3). Following a single 1 h of
75 lM menadione pulse, mitochondrial protein degradation
signiﬁcantly increased from 63.6% ± 5.8% in untreated cells
to 90.3% ± 8.9% in menadione treated cells over a 7 h period
(P < 0.01, n = 3) (Fig. 1).
3.4. Individual mitochondrial proteins show distinct diﬀerences in
their responses to oxidative stress
Because the pulse chase methods used above could be signif-
icantly inﬂuenced by the degradation of a few abundant pro-teins we further separated mitochondrial proteins by 2D gel
electrophoresis. Separation of metabolically labeled mitochon-
drial proteins using a 2D isoelectric focusing and SDS–PAGE
protocol resulted in the resolution of over 100 labeled proteins
(Fig. 4). The eﬀect of oxidative stress on individual newly syn-
thesized mitochondrial proteins was determined by following
decay of individual spots with and without exposure to
75 lM menadione over a 3 h period. Mitochondrial proteins
showing the highest rates of metabolic labeling were selected
for degradation analysis (Fig. 4). Unlike the overall accelerated
rate of mitochondrial protein degradation observed in
Fig. 1(ii), individual rates of mitochondrial protein degrada-
tion showed both increased and slowed rates of turnover
(Fig. 5). Five of the 21 labeled proteins were readily detectable
by coomassie staining and were excised and subjected to mass
spec sequence analysis. Four of the proteins were successfully
identiﬁed as mitochondrial proteins: spots 3 and 4 were both
identiﬁed as the ATP synthase d chain, spot 5 the a subunit
of the F1 component of ATP synthase and spot 13 Heat shock
protein 60 (HSP60). The proteins identiﬁed also diﬀered in
their susceptibility to oxidative stress. One of the ATP syn-
thase d chain peptides (spot 4) and the a subunit of the F1
component of ATP synthase both showed slowed rates of turn-
over following menadione treatment while the second ATP
synthase d chain peptides (spot 3) and Hsp60 showed slight in-
creases in newly synthesized degradation following oxidative
stress (Fig. 5).
3.5. Oxidative stress impairs protein synthesis
Oxidative stress might also impair new protein synthesis,
which in addition to the accelerated rates of newly synthesized
mitochondrial protein degradation could in the long-term re-
sult in generalized mitochondrial enzyme deﬁciencies. Expo-
sure of C2C12 cells to a 1 h of 75 lm menadione pulse
followed by 35S-methionine labeling signiﬁcantly reduced cel-
lular protein synthesis to 26% ± 3% of untreated control levels
(P = 0.002, n = 3).
Fig. 2. Menadione treatment increases levels of intracellular ROS. (A)
1 mM menadione signiﬁcantly increased hydrogen peroxide associated
DCFA-DA ﬂuorescence relative to untreated controls (P < 0.001,
n = 3). Co-exposure of 1 mM menadione with the antioxidant NAC
reduced DCFA-DA ﬂuorescence almost to the level of untreated cells.
(B) Exposure of cells to 1 mM menadione resulted in an initial burst of
superoxide associated lucigenin luminescence shown as an increase in
relative light units (rlu). Superoxide levels peaked at 140 rlu after
2 min, dropping to 40 rlu over the following 3 min. This was followed
by a sustained 20-fold increase in production of superoxide anions over
the following 30 min (ii). When cells were co-exposed to 1 mM
menadione and the antioxidant NAC, there was no detectable increase
in superoxide production (iii).
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Although there is clear evidence that biological components
of living systems are susceptible to free radical mediated dam-
age, it remains uncertain as to whether the oxidation of lipids,
DNA or proteins plays a fundamental role in the pathogenesis
of clinical disease. In this study we have utilized a pharmaco-
logical model of free radical generation, using the compound
menadione, which causes the generation of free radical species
within the mitochondria [24]. Although menadione has also
been proposed to increased levels of protein thiolation its ma-
jor toxic eﬀect appears to be via increased free radical genera-
tion from the respiratory chain [25,26]. As mitochondria are
potentially the major site of free radical production in most
cells and tissues, this model mimics what many researchers be-
lieve to be occurring in a variety of disease states [27–29]. Un-like other mitochondrial free radical generators including
rotenone and antimycin A which generate free radicals by
blocking the respiratory chain, menadione generates free radi-
cals within the mitochondria by short circuiting the respiratory
chain, taking electrons from ubiquinone and passing them di-
rectly onto molecular oxygen generating superoxide.
In this study we investigated the eﬀect of mitochondrially
generated radicals on newly synthesized mitochondrial protein
degradation. To investigate how low doses of mitochondrial
ROS might aﬀect biological function over time, we selected
doses of menadione that had minimal aﬀect on cell viability
and ROS sensitive mitochondrial enzyme function. Previous
studies suggest that mild oxidative modiﬁcation of cellular pro-
teins facilitates their removal [4,7]. As newly synthesized pro-
teins comprise a very small fraction of the total protein pool
we did not observe any diﬀerence in the levels of steady state
proteins following menadione treatment (data not shown).
However, it is likely that proteins showing increased newly
synthesized degradation and reduced synthesis would eventu-
ally show reduced levels of steady state proteins if exposed
to low levels of ROS in the long term.
Increased susceptibility of unassembled proteins is observed
in a number of genetic disorders where the changed conforma-
tion of themutant protein targets the protein for degradation be-
fore it is assembled. Examples include the common DF508
mutation causing cystic ﬁbrosis, Glucocerbrocidase mutations
causing Gauchers disease and mutations in the pyruvate dehy-
drogenase (PDH) E1 a subunit causing PDH deﬁciency. All
three of thesemutant proteins have faster degradation rates than
their wild type proteins [11–13]. Although not studied exten-
sively, the process of protein synthesis and assembly of normal
proteins seems a very ineﬃcient one. In the case of the normal
CFTR chloride channel, approximately 90% of the newly syn-
thesized protein is not assembled but is degraded by the protea-
some as part of the normal cellular quality control system [12].
Why this occurs is unclear, but it is possible that a signiﬁcant
amount of oxidative protein damage occurs to proteins even un-
der normal conditions and modiﬁed proteins are removed to
prevent aberrant protein complexes being assembled.
Our results support previous ﬁndings showing that even un-
der non-stressed conditions newly synthesized proteins are par-
ticularly prone to degradation [12]. We have focused on
mitochondrial proteins generated during a 2-h metabolic label-
ing period in order to speciﬁcally study newly synthesized
mitochondrial protein degradation. Mitochondrial respiratory
chain complexes once assembled are extremely stable, many
having half lives of up to 7 days [30–32]. Proteins appear more
prone to damage induced degradation during the assembly
process and are far more stable when fully assembled. As
assembly pathways diﬀer widely in their complexity, this insta-
bility is likely to vary dramatically for diﬀerent proteins. When
exposed to low levels of menadione-induced mitochondrial
radicals, newly synthesized mitochondrial degradation rates
are signiﬁcantly increased from 64% of proteins being de-
graded after 7 h in untreated cells to 90% following 75 lM
menadione treatment (P < 0.01) (Fig. 1). This result is similar
to Grune et al [9] looking at the whole cellular protein fraction
who showed a general increase in cellular protein degradation
following low-dose menadione treatment in rat epithelial cells.
Although newly synthesized mitochondrial proteins show a
general increase in degradation following oxidative stress
(Fig. 1), when examined on the single protein level the response
Fig. 3. Cell death pathways are not induced by a 1 h of 75 lM menadione treatment. Following a 1-h incubation in methionine free media C2C12
myoblasts were exposed to either a single 1-h pulse of 75 lM and 1 mM menadione. Cells were washed with PBS and incubated in standard cell
culture medium for 24 h at 37 C. Cells were subsequently stained with both Annexin-V and PI and analyzed by FACscan ﬂow cytometry. Apoptotic
cells stained positive for Annexin-V only (lower right quadrant), necrotic cells stained positive for PI only (upper left quadrant), early necrotic cells
stained for both Annexin-V and PI (upper right quadrant), healthy cells were negative for both Annexin-V and PI (lower left quadrant). The X-axis
measures cell size and the Y-axis measures cell granularity. A representative experiment (out of ﬁve) is shown.
Fig. 4. Illustration of how 2D protein gel analysis can be used to determine mitochondrial protein degradation rates. Mitochondrial fractions were
labeled, extracted and separated as outlined in Sections 2.3 and 2.4. A typical series of gels are shown for a control experiment: (A) the level of 35S-
methionine radiolabel incorporated into mitochondrial proteins at time 0 and (B) the reduction in radioactivity of control mitochondrial proteins
after a 3 h cold chase. The radiolabelled proteins outlined were subjected to phosphoimage analysis and rates of degradation calculated for untreated
cells and following 75 lM menadione treatment. The results are shown in Fig. 5.
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Fig. 5. Newly synthesized mitochondrial proteins diﬀer in their response to oxidative stress. The degradation rates of mitochondrial proteins diﬀer in
their response to mitochondrially generated radicals. Protein degradation is expressed for each spot as the % of radiolabeled protein degraded by 3 h,
a value of 100% indicates all the newly synthesized protein has been degraded. Spots identiﬁed by mass spectrometry: spots 3 and 4 ATP synthase d
subunit, spot 5 a subunit of the F1 component of ATP synthase and spot 13 HSP60. This ﬁgure is a single experiment highlighting the power of our
pulse chase mitochondrial isolation system in identifying mitochondrial target proteins which are sensitive to oxidative stress.
6516 A. Basoah et al. / FEBS Letters 579 (2005) 6511–6517was much more heterogeneous. Most mitochondrial proteins
quantiﬁed showed faster rates of degradation following oxida-
tive stress but others (spots 4, 5, 6, 10, 11, 17 and 18) show slo-
wed rates of degradation (Fig. 5). Three mitochondrial
proteins: spots 4, 20 and 14 show quite dramatic changes in
their degradation proﬁles following oxidative stress, spot 4
shows a reduction in turnover of 55% while spots 20 and 14
show increases in turnover rates of 65% and 69%, respectively
(Fig. 5). Due to limitations in the amount of steady state mito-
chondrial proteins available for proteins showing altered rates
of degradation we were unable to determine the identify the
majority of the mitochondrial proteins showing oxidative
stress altered rates of turnover.
Two of the mitochondrial proteins (spots 3 and 4, Fig. 4)
were shown by peptide sequence analysis to be the mitochon-
drial ATP synthase d subunit which anchors the F1 matrix mo-
tor part of the mitochondrial ATPsynthase to the inner
membrane spanning F0 component [33]. The higher than pre-
dicted mobility of spot 4 could be the result of a break down
product of the full length protein (spot 3), Alternatively, the
lower molecular weight species (spot 4) could represent the ma-
ture form of the pro-form (spot 3) of the mitochondrial ATP
synthase d subunit. Interestingly these two proteins diﬀer in
their response to oxidative stress as measured by changes in
their newly synthesized degradation rates. The higher molecu-
lar weight species (spot 3) showed little change in its rate of
degradation while the lower molecular weight species (spot
4) was stabilized signiﬁcantly with menadione treatment. If
the lower molecular weight species is a breakdown product,
the reduced degradation following oxidative stress may indi-
cate that extensive protein oxidation has occurred to the point
where the protein becomes resistant to proteolysis and is there-
fore liable to build up within the mitochondria. It is possible
that some of the radiolabelled mitochondrial proteins identi-
ﬁed by 2D electrophoresis are derived from proteins that have
been assembled during the cold chase period. We are therefore
unable to discount the possibility that the accumulative eﬀects
of menadione induced oxidative stress aﬀects assembled as well
newly synthesized mitochondrial proteins.
A recent study by Kujoth et al. [34] suggests that tissues
from mice containing high levels of mtDNA mutations donot increase levels of mitochondrial ROS or oxidatively dam-
aged proteins. Mice with defective polymerase gamma mani-
fest certain features that are typical of human aging but
others, such as the pattern of mtDNA mutations that are
not [34,35]. It is by no means clear that mtDNA mutations
are involved in all types of mitochondrial age-related oxidative
stress.Our data suggest that low levels of mitochondrial ROS
can aﬀect speciﬁc newly synthesized proteins which in the long
term could aﬀect protein levels. A signiﬁcant diﬀerence be-
tween our study and that of Kujoth is that in our system the
cells had very little time to increase levels of antioxidant de-
fences to cope with the increased levels of mitochondrial
ROS. Cell based studies on rho-cells and cells containing path-
ogenic mtDNA mutations show signiﬁcant increases in levels
of the mitochondrial manganese superoxide dismutase
[25,36]. The mitochondrial polymerase c mutant mice used
by Kujoth and an early study by Trifunovnic take 36 and 25
weeks, respectively, to develop symptoms in which time anti-
oxidant enzymes could be activated to deal with increasing lev-
els of mitochondrial ROS [34,35]. In addition the current
methods for measuring ROS may not be sensitive enough to
measure low levels of ROS capable of causing biological dam-
age. The 1 h of 75 lM menadione pulse used in our study did
not result in a signiﬁcant increase in DCFH-DA ﬂuorescence
(data not shown) but did signiﬁcantly aﬀect the rate of newly
synthesized mitochondrial protein turnover. Until mouse mod-
els can be generated allowing both chronic and acute bursts of
oxidative stress at levels consistent with that observed in aging
and disease, we can not be sure whether increased mitochon-
drial oxidative stress is an important factor in aging or age
associated diseases.5. Conclusions
We demonstrate that newly synthesized mitochondrial pro-
teins have very fast rates of degradation, the majority being de-
graded within 24 h of synthesis. Low levels of menadione
inducedmitochondrial oxidative stress aﬀectedprotein synthesis
and signiﬁcantly increased the overall rate of newly synthesized
mitochondrial protein degradation. By utilizing a combination
A. Basoah et al. / FEBS Letters 579 (2005) 6511–6517 651735S-methionine metabolic labeling, mitochondrial isolation, 2D
protein analysis and mass spectrometry we were able to follow
the fate of individual newly synthesized mitochondrial proteins.
At the single protein level newly synthesized mitochondrial pro-
teins diﬀered in their response to oxidative stress. As expected
the majority showed increased rates of degradation but others
showed slowed rates of degradation. Identiﬁcation of the more
abundant mitochondrial proteins aﬀected by oxidative stress
demonstrated the utility of our approach in identifying diﬀeren-
tially degraded/processed peptides (i.e., the mitochondrial ATP
d subunit). Future studies combining our post-translational ap-
proach with gene expression proﬁling will allow one to deter-
mine whether changes observed at the protein level are
translational or post translational in origin. In disease associated
research such an approachwill both identify susceptible proteins
and deﬁne the appropriate areas where intervention is most
likely to succeed.
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